-
- C Grau.
- Kraeftens Bekaempelses afdeling for eksperimental klinisk onkologi, Arhus.
- Ugeskr. Laeg. 1993 Jan 25; 155 (4): 208-11.
AbstractThe current clinical and biological knowledge about radiation myelopathy is reviewed. Transient myelopathy with Lhermitte's sign develops within months after irradiation. Symptoms generally disappear within months without treatment. Chronic progressive radiation myelopathy develops with a latency of several months to years after spinal cord irradiation. The symptoms are paraesthesia, paresis or paralysis, leading to severe physical disability and eventually death due to secondary infections. The long term survival after myelopathy is 30% for cervical myelopathy and 70% for thoracic myelopathy. There is no effective treatment. Analysis of clinical reports shows that the risk of developing chronic myelopathy is less than 2% after 55 Gy, given in 2 Gy daily fractions. Other important radiobiological risk factors (dose per fraction, interfraction interval and volume) are discussed.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.